1,3,4-oxadiazole has been researched along with Neoplasms in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 5 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhandari, S; Patil, S | 1 |
| Aydın, E; Güzel, M; Küçük, HB; Şentürk, AM | 1 |
| Åstrand, A; Collins, M; Ek, M; Gunnarsson, A; Hughes, G; Johansson, J; Jung, B; Li, Q; Llinas, A; Mogemark, M; Novén, A; Pemberton, N; Ripa, L; Sandmark, J; Shamovsky, I; Tångefjord, S; Xiong, Y | 1 |
| Ahsan, MJ | 1 |
| Ahmad, M; Andrei, G; Dânoun, K; El Mansouri, AE; Jochmans, D; Lazrek, HB; Morjani, H; Neyts, J; Oubella, A; Snoeck, R; Zahouily, M | 1 |
| Bajaj, S; Roy, PP; Singh, J | 1 |
| Glomb, T; Świątek, P; Szymankiewicz, K | 1 |
| He, LQ; Jiang, AQ; Liu, ZJ; Luo, Y; Yang, YH; Zhang, S; Zhu, HL | 1 |
| Cui, JR; Ge, ZM; Li, RD; Li, RT; Li, YB; Liu, P; Sun, SQ; Wang, X; Yan, X; Zhou, DM | 1 |
| Lu, GH; Pang, YJ; Qi, JL; Qiu, HY; Sun, WX; Wang, X; Wang, XM; Wang, ZZ; Yang, YH; Yu, FG; Zhang, YH | 1 |
4 review(s) available for 1,3,4-oxadiazole and Neoplasms
| Article | Year |
|---|---|
A Review: Discovering 1,3,4-oxadiazole and Chalcone Nucleus for Cytotoxicity / EGFR Inhibitory Anticancer Activity.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Chalcone; Drug Design; Drug Screening Assays, Antitumor; ErbB Receptors; Humans; Molecular Structure; Neoplasms; Oxadiazoles; Structure-Activity Relationship | 2022 |
1,3,4-Oxadiazole Containing Compounds As Therapeutic Targets For Cancer Therapy.
Topics: Antineoplastic Agents; Drug Design; Humans; Molecular Docking Simulation; Molecular Structure; Neoplasms; Oxadiazoles; Structure-Activity Relationship | 2022 |
1,3,4-Oxadiazoles as Telomerase Inhibitor: Potential Anticancer Agents.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Enzyme Inhibitors; Humans; Molecular Structure; Neoplasms; Oxadiazoles; Telomerase | 2018 |
Anti-Cancer Activity of Derivatives of 1,3,4-Oxadiazole.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Humans; Molecular Structure; Neoplasms; Oxadiazoles; Structure-Activity Relationship | 2018 |
6 other study(ies) available for 1,3,4-oxadiazole and Neoplasms
| Article | Year |
|---|---|
Cytotoxic Activity and Docking Studies of 2-arenoxybenzaldehyde N-acyl Hydrazone and 1,3,4-Oxadiazole Derivatives against Various Cancer Cell Lines.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Hydrazones; Molecular Docking Simulation; Molecular Structure; Neoplasms; Oxadiazoles; Structure-Activity Relationship | 2022 |
Selective and Bioavailable HDAC6 2-(Difluoromethyl)-1,3,4-oxadiazole Substrate Inhibitors and Modeling of Their Bioactivation Mechanism.
Topics: Animals; Histone Deacetylase 6; Histone Deacetylase Inhibitors; Mice; Neoplasms; Oxadiazoles; Rats; Tubulin | 2023 |
Discovery of novel furo[2,3-d]pyrimidin-2-one-1,3,4-oxadiazole hybrid derivatives as dual antiviral and anticancer agents that induce apoptosis.
Topics: Acyclovir; Antineoplastic Agents; Antiviral Agents; Apoptosis; Caspase 3; Cell Line, Tumor; Herpesvirus 3, Human; Humans; Molecular Docking Simulation; Neoplasms; Oxadiazoles; Pyrimidines; Structure-Activity Relationship | 2021 |
Synthesis, biological evaluation, and molecular docking studies of novel 1,3,4-oxadiazole derivatives possessing benzotriazole moiety as FAK inhibitors with anticancer activity.
Topics: Antineoplastic Agents; Focal Adhesion Protein-Tyrosine Kinases; HT29 Cells; Humans; MCF-7 Cells; Molecular Docking Simulation; Neoplasms; Oxadiazoles; Protein Kinase Inhibitors; Structure-Activity Relationship; Triazoles | 2013 |
Discovery of novel heteroarylmethylcarbamodithioates as potent anticancer agents: Synthesis, structure-activity relationship analysis and biological evaluation.
Topics: Antineoplastic Agents; Cell Cycle Checkpoints; Cell Line; Cell Line, Tumor; Cell Proliferation; Drug Design; Drug Screening Assays, Antitumor; Humans; Neoplasms; Oxadiazoles; Structure-Activity Relationship; Thiocarbamates | 2016 |
Design, synthesis, biological evaluation, and 3D-QSAR analysis of podophyllotoxin-dioxazole combination as tubulin targeting anticancer agents.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Drug Design; Drug Screening Assays, Antitumor; Humans; Molecular Docking Simulation; Neoplasms; Oxadiazoles; Podophyllotoxin; Quantitative Structure-Activity Relationship; Tubulin; Tubulin Modulators | 2017 |